Search research articles
Contact Us
Filters
Showing results (421-430 of 476) with videos related to
Page
of 48
Sort By:
Journal of Alzheimer'S Disease : JAD
|
March 9, 2017
Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia
Amani Alghamdi, Julie Vallortigara, David R Howlett, et al.
Neuroimage
|
May 3, 2005
GLM-beamformer method demonstrates stationary field, alpha ERD and gamma ERS co-localisation with fMRI BOLD response in visual cortex
Matthew J Brookes, Andrew M Gibson, Stephen D Hall, et al.
The Journal of Pharmacy and Pharmacology
|
February 21, 2008
Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels
Sawsan Abuhamdah, Liping Huang, Mark S J Elliott, et al.
Brain Pathology (Zurich, Switzerland)
|
July 28, 2018
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration
Yuek Ling Chai, Joyce R Chong, Jiaju Weng, et al.
Journal of Neuroinflammation
|
May 9, 2023
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias
Yuek Ling Chai, Jasinda H Lee, Joyce R Chong, et al.
Journal of Alzheimer'S Disease : JAD
|
December 8, 2015
Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia
Julie Vallortigara, David Whitfield, William Quelch, et al.
Journal of Alzheimer'S Disease : JAD
|
June 20, 2018
Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort
Keeley J Brookes, George McConnell, Kirsty Williams, et al.
Lancet (London, England)
|
January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial
Marisa Hanney, Vee Prasher, Nicola Williams, et al.
Neuroimage
|
November 6, 2004
A general linear model for MEG beamformer imaging
Matthew J Brookes, Andrew M Gibson, Stephen D Hall, et al.
Neurochemistry International
|
November 9, 2013
Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with Aβ burden
Michelle G K Tan, Chingli Lee, Jasinda H Lee, et al.
Page
of 48
Search research articles
Search
Showing results (421-430 of 476) with videos related to
Sort By:
Page
of 48
Journal of Alzheimer'S Disease : JAD
|
March 9, 2017
Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia
Amani Alghamdi, Julie Vallortigara, David R Howlett, et al.
Neuroimage
|
May 3, 2005
GLM-beamformer method demonstrates stationary field, alpha ERD and gamma ERS co-localisation with fMRI BOLD response in visual cortex
Matthew J Brookes, Andrew M Gibson, Stephen D Hall, et al.
The Journal of Pharmacy and Pharmacology
|
February 21, 2008
Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels
Sawsan Abuhamdah, Liping Huang, Mark S J Elliott, et al.
Brain Pathology (Zurich, Switzerland)
|
July 28, 2018
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration
Yuek Ling Chai, Joyce R Chong, Jiaju Weng, et al.
Journal of Neuroinflammation
|
May 9, 2023
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias
Yuek Ling Chai, Jasinda H Lee, Joyce R Chong, et al.
Journal of Alzheimer'S Disease : JAD
|
December 8, 2015
Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia
Julie Vallortigara, David Whitfield, William Quelch, et al.
Journal of Alzheimer'S Disease : JAD
|
June 20, 2018
Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort
Keeley J Brookes, George McConnell, Kirsty Williams, et al.
Lancet (London, England)
|
January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial
Marisa Hanney, Vee Prasher, Nicola Williams, et al.
Neuroimage
|
November 6, 2004
A general linear model for MEG beamformer imaging
Matthew J Brookes, Andrew M Gibson, Stephen D Hall, et al.
Neurochemistry International
|
November 9, 2013
Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with Aβ burden
Michelle G K Tan, Chingli Lee, Jasinda H Lee, et al.
Page
of 48